|
|
|
|
|
|
by msla
1052 days ago
|
|
|
We're making good strides in some areas and others are more resistant to breakthroughs. This even works in different aspects of the same thing: We have the ability to genetically modify T-cells to kill some kinds of cancers, but it's more difficult to use that against solid tumors, which create their own microenvironments inside of them, than blood cancers. https://stemcellres.biomedcentral.com/articles/10.1186/s1328... But, of course, we keep making progress, and there's been some promising results in making CAR T-cell therapies that work against solid tumors: https://www.cancernetwork.com/view/cldn6-car-t-cell-therapy-... We advance piecemeal and some things are more difficult than others, but we definitely advance. |
|
|